ArticlemSphere2019
Dectin-1-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy.
Erratum issuedOpen access · goldAbstract read
In one paragraph
Article in mSphere, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 35 papers.
0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 53 citations in OpenAlex.
- New approaches for cryptococcosis treatment and prevention-a systematic review.Journal of thoracic disease · 2026Review
- Human Dectin-1- and Dectin-2-targeted DectiSomes are effective against diverse pathogenic fungi.Antimicrobial agents and chemotherapy · 2026Article
- Integrative computational-experimental discovery and translation of antifungal peptides for multidrug-resistant fungi.Frontiers in microbiology · 2026Review
- Pathogenesis and Triazole Resistance inInfection and drug resistance · 2026Review
- Advancing antifungal therapy: exploring targeted CFW-PEc-enhanced ethosomal formulations of amphotericin B against cryptococcal pneumonia.Microbiology spectrum · 2025Article
- Nanovesicular Drug Delivery Systems for Rare Ocular Diseases: Advances, Challenges, and Future Directions.AAPS PharmSciTech · 2025Review
- Aspergillosis: A comprehensive review of pathogenesis, drug resistance, and emerging therapeutics.Journal of food and drug analysis · 2025Review
- Altering the ligand specificity of DectiSomes.The Journal of biological chemistry · 2025Article
- Siglec-targeted liposomes to identify sialoglycans present on fungal pathogens.Antimicrobial agents and chemotherapy · 2025Article
- Recent developments inMicrobiology and molecular biology reviews : MMBR · 2025Review
- An overview of the mechanistic approaches of antifungal nanomaterials.Frontiers in pharmacology · 2025Review
- Anionic lipids direct efficient microfluidic encapsulation of stable and functionally active proteins in lipid nanoparticles.Communications materials · 2025Article
- The progress and future of the treatment of Candida albicans infections based on nanotechnology.Journal of nanobiotechnology · 2024Review
- Manipulation of host phagocytosis by fungal pathogens and therapeutic opportunities.Nature microbiology · 2024Review
- Cryo-EM reconstruction of oleate hydratase bound to a phospholipid membrane bilayer.Journal of structural biology · 2024Article
- All hands on Dec: Treating cryptococcosis with dectin decorated liposomes loaded with antifungals.iScience · 2024Article
- Host Transcriptional Regulatory Genes and Microbiome Networks Crosstalk through Immune Receptors Establishing Normal and Tumor Multiomics Metafirm of the Oral-Gut-Lung Axis.International journal of molecular sciences · 2023Review
- Dectin-3-targeted antifungal liposomes efficiently bind and kill diverse fungal pathogens.Molecular microbiology · 2023Article
- Metal Nanomaterials and Hydrolytic Enzyme-Based Formulations for Improved Antifungal Activity.International journal of molecular sciences · 2023Review
- DectiSomes: C-type lectin receptor-targeted liposomes as pan-antifungal drugs.Advanced drug delivery reviews · 2023Review
Corrections and comments
- Erratum issued
Authors and funding
8 authors at 1 institution in 1 country.
Suresh AmbatiDepartment of Genetics, University of Georgia, Athens, Georgia, USA.
Aileen R FerarroDepartment of Microbiology, University of Georgia, Athens, Georgia, USA.
S Earl KangFungal Biology Group and Department of Plant Biology, University of Georgia, Athens, Georgia, USA.
Jianfeng LinDepartment of Microbiology, University of Georgia, Athens, Georgia, USA.
Xiaorong LinDepartment of Microbiology, University of Georgia, Athens, Georgia, USA.ORCID 0000-0002-3390-8387
Michelle MomanyFungal Biology Group and Department of Plant Biology, University of Georgia, Athens, Georgia, USA.
Zachary A LewisDepartment of Microbiology, University of Georgia, Athens, Georgia, USA.
Richard B MeagherDepartment of Genetics, University of Georgia, Athens, Georgia, USA meagher@uga.edu.ORCID 0000-0003-3928-8403
University of Georgia · US
Funding
Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1MDefining the genetic network governing cryptococcal morphological transitionR01AI140719 · NIAID · UNIVERSITY OF GEORGIA · PI Xiaorong Lin · 2018 to 2026
$4.1MTargeted Pan-Antifungal LiposomesR01AI162989 · NIAID · UNIVERSITY OF GEORGIA · PI Zachary Lewis, Richard Brian Meagher · 2022 to 2026
$2.6MAntifungal ImunoliposomesR21AI144498 · NIAID · UNIVERSITY OF GEORGIA · PI MEAGHER, RICHARD BRIAN · 2019 to 2020
$415kNCATS NIH HHS UL1 TR002378NIAID NIH HHS R01 AI140719NIAID NIH HHS R01 AI162989NIAID NIH HHS R21 AI144498
Abstract
PubMed holds no abstract for this paper.
Indexed as
Amphotericin BAnimalsAntifungal AgentsAspergillosisAspergillus fumigatusCandida albicansCell SurvivalCell WallCryptococcus neoformansDectin-1HEK293 CellsHumansLectins, C-TypeLiposomesMiceProtein BindingAmphotericin BAntifungal AgentsDectin-1Lectins, C-Typeliposomal amphotericin BLiposomesamphotericin Bantifungal agentsaspergillosisAspergillus fumigatusbeta-glucanscell walldectin-1experimental therapeuticsfungicidalinnate immune receptorliposomes
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.